Ensysce Biosciences (ENSC) Return on Capital Employed (2021 - 2025)
Historic Return on Capital Employed for Ensysce Biosciences (ENSC) over the last 5 years, with Q3 2025 value amounting to 5.33%.
- Ensysce Biosciences' Return on Capital Employed fell 34100.0% to 5.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.33%, marking a year-over-year decrease of 34100.0%. This contributed to the annual value of 3.46% for FY2024, which is 76600.0% up from last year.
- Per Ensysce Biosciences' latest filing, its Return on Capital Employed stood at 5.33% for Q3 2025, which was down 34100.0% from 2.58% recorded in Q2 2025.
- In the past 5 years, Ensysce Biosciences' Return on Capital Employed registered a high of 29.0% during Q4 2023, and its lowest value of 23.79% during Q1 2023.
- Its 5-year average for Return on Capital Employed is 1.14%, with a median of 2.05% in 2025.
- In the last 5 years, Ensysce Biosciences' Return on Capital Employed skyrocketed by 188100bps in 2023 and then plummeted by -302700bps in 2024.
- Over the past 5 years, Ensysce Biosciences' Return on Capital Employed (Quarter) stood at 5.81% in 2021, then surged by 75bps to 10.19% in 2022, then soared by 185bps to 29.0% in 2023, then tumbled by -104bps to 1.27% in 2024, then tumbled by -318bps to 5.33% in 2025.
- Its Return on Capital Employed stands at 5.33% for Q3 2025, versus 2.58% for Q2 2025 and 2.05% for Q1 2025.